US Patent

US9993483 — Compositions and methods for treating ophthalmic, octic, or nasal infections

Formulation · Assigned to Alcon Research LLC · Expires 2030-07-02 · 4y remaining

Vulnerability score 56/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects methods and compositions for treating ophthalmic, otic, or nasal infections using finafloxacin or a finafloxacin derivative.

USPTO Abstract

The present invention relates to methods for treating an ophthalmic, otic, or nasal infection comprising treating the infected tissue with a composition comprising finafloxacin or a finafloxacin derivative. The present invention also relates to antimicrobial compositions comprising finafloxacin or a finafloxacin derivative. The compositions are suitable for the treatment of ophthalmic, otic, or nasal infections.

Drugs covered by this patent

Patent Metadata

Patent number
US9993483
Jurisdiction
US
Classification
Formulation
Expires
2030-07-02
Drug substance claim
No
Drug product claim
Yes
Assignee
Alcon Research LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.